利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.014 秒)

    Dietary compositions and methods
    1.
    发明授权
    Dietary compositions and methods 有权
    膳食成分和方法

    公开(公告)号：US06359017B1

    公开(公告)日：2002-03-19

    申请号：US09512577

    申请日：2000-02-24

    申请人： Geza Bruckner ,  Joseph Szabo

    发明人： Geza Bruckner ,  Joseph Szabo

    IPC分类号： A61P304

    CPC分类号： A23K50/40 ,  A23K20/10 ,  A23K20/111 ,  A23K20/158 ,  A23K20/163 ,  A23K20/168 ,  A23K20/184 ,  A23K20/20 ,  A23K50/00 ,  A23K50/20 ,  A23L33/11 ,  A61K31/35 ,  A61K31/365 ,  A61K31/37 ,  A61K45/06 ,  A61K2300/00

    摘要： Dietary compositions and methods employ a mammal food base and a component comprising estrogen, androgen or a mixture thereof in an amount sufficient to reduce weight gain normally incurred in the mammal type subsequent to neutering, castration, spaying, ovariectomy or ovariohysterectomy, or post menopause. Preferably, the component comprises phytoestrogen, phytoandrogen or a mixture thereof. The compositions are adapted for administration to the mammal on a regular, preferably daily, basis.

    摘要翻译： 饮食组合物和方法使用哺乳动物食物基质和包含雌激素，雄激素或其混合物的组分，其含量足以减少在阉割，去势，喷洒，卵巢切除术或卵巢切除术或更年期后通常在哺乳动物类型中发生的体重增加。 优选地，组分包括植物雌激素，植物雄激素或其混合物。 该组合物适于以规则，优选每日为基础向哺乳动物施用。

    Comprehensive pharmacologic therapy for treatment of obesity
    3.
    发明授权
    Comprehensive pharmacologic therapy for treatment of obesity 失效
    综合药理治疗肥胖症

    公开(公告)号：US06403657B1

    公开(公告)日：2002-06-11

    申请号：US09412701

    申请日：1999-10-05

    申请人： Martin C. Hinz

    发明人： Martin C. Hinz

    IPC分类号： A61P304

    CPC分类号： A61K31/34 ,  A61K31/198 ,  A61K31/343 ,  A61K31/375 ,  A61K31/405 ,  A61K31/4415 ,  A61K33/06 ,  Y10S514/905 ,  Y10S514/909 ,  Y10S514/91 ,  A61K31/44 ,  A61K31/195 ,  A61K31/135 ,  A61K2300/00

    摘要： The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for brief and long durations which may be 12 months or more. The preferred procedure involves the administration of drugs in combination which are identified as: Citalopram (Celexa) and Phentermine; Citalopram (Celexa) and Diethylpropion; Citalopram (Celexa), Phentermine, and Diethylpropion. In addition nutritional supplementation such as a multivitamin, 5-Hydroxytryptophan, vitamin B6, vitamin C, Tyrosine, Calcium, and Lysine may be used to enhance the performance of the weight loss treatment program.

    摘要翻译： 用于治疗肥胖症的综合药理学疗法是一种方法，其涉及施用期望的治疗范围的二乙基丙酸和/或苯丁胺与SSRI药物和营养补充剂组合，用于短暂和长时间，其可能为12个月或更长。 优选的方法包括组合给药，其被鉴定为：西酞普兰（Celexa）和苯丁胺; 西酞普兰（Celexa）和二乙基丙酸酯; 西酞普兰（Celexa），苯丁胺和二乙基丙酸。 此外，还可以使用营养补充剂如多种维生素，5-羟色氨酸，维生素B6，维生素C，酪氨酸，钙和赖氨酸来增强减肥治疗程序的性能。

    Comprehensive pharmacologic therapy for treatment of obesity including cysteine
    5.
    发明授权
    Comprehensive pharmacologic therapy for treatment of obesity including cysteine 失效
    综合治疗肥胖包括半胱氨酸的药物治疗

    公开(公告)号：US06759437B2

    公开(公告)日：2004-07-06

    申请号：US09947941

    申请日：2001-09-06

    申请人： Martin C. Hinz

    发明人： Martin C. Hinz

    IPC分类号： A61P304

    CPC分类号： A61K31/34 ,  A61K31/137 ,  A61K31/198 ,  A61K31/404 ,  A61K31/714 ,  A61K33/06 ,  Y10S514/905 ,  Y10S514/909 ,  A61K2300/00 ,  A61K31/44 ,  A61K31/405 ,  A61K31/375 ,  A61K31/195 ,  A61K31/135

    摘要： The comprehensive pharmacologic therapy for treatment of obesity including Cysteine is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for brief and long durations which may be 12 months or more. The preferred procedure involves the administration of drugs in combination which are identified as: Citalopram (Celexa) and Phentermine; Citalopram (Celexa) and Diethylpropion; Citalopram (Celexa), Phentermine, and Diethylpropion. In addition nutritional supplementation such as a multivitamin, 5-Hydroxytryptophan, Cysteine, vitamin B6, vitamin C, Tyrosine, Calcium, and Lysine may be used to enhance the performance of the weight loss treatment program.

    摘要翻译： 用于治疗包括半胱氨酸在内的肥胖症的综合药理学治疗方法是涉及将期望的治疗范围的二乙基丙酸和/或苯丁胺与SSRI药物和营养补充剂一起施用于短暂且持续时间长达12个月或更长时间的方法。 优选的方法包括组合给药，其被鉴定为：西酞普兰（Celexa）和苯丁胺; 西酞普兰（Celexa）和二乙基丙酸酯; 西酞普兰（Celexa），苯丁胺和二乙基丙酸。 此外，还可以使用营养补充剂如多种维生素，5-羟色氨酸，半胱氨酸，维生素B6，维生素C，酪氨酸，钙和赖氨酸来增强减肥治疗方案的性能。

    Materials and methods for the treatment or prevention of obesity
    8.
    发明授权
    Materials and methods for the treatment or prevention of obesity 有权

    公开(公告)号：US06384087B1

    公开(公告)日：2002-05-07

    申请号：US09654357

    申请日：2000-09-01

    申请人： Michael B. Zemel ,  Hang Shi ,  Paula C. Zemel

    发明人： Michael B. Zemel ,  Hang Shi ,  Paula C. Zemel

    IPC分类号： A61P304

    CPC分类号： A61K31/00 ,  A23L33/16 ,  A23L33/30 ,  Y10S514/905

    摘要： The subject invention provides methods of inducing the loss of adipose tissue by providing a diet high in calcium. In one aspect of the invention, the calcium is provided in the form of dairy products. In yet another aspect of the invention, calcium is provided in the form of a dietary supplement, such as calcium carbonate, of vitamin supplements. Methods of suppressing [Ca2+]i levels in individuals are also provided. The subject invention also provides methods of stimulating lipolysis, inhibiting lipogenesis, and increasing the expression of white adipose tissue uncoupling protein 2 (UCP2). The subject invention also provides methods of increasing the core temperature of an individual.